Shares of MINDBODY Inc (NASDAQ:MB) have received a consensus rating of “Buy” from the nine research firms that are presently covering the stock. Two research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The average 12-month target price among brokers that have issued a report on the stock in the last year is $29.00.

Several equities research analysts have recently issued reports on MB shares. Zacks Investment Research lowered MINDBODY from a “buy” rating to a “hold” rating in a report on Tuesday, February 7th. Roth Capital set a $28.00 price target on MINDBODY and gave the stock a “buy” rating in a research report on Monday, February 6th. Imperial Capital lifted their price target on MINDBODY from $25.00 to $30.00 and gave the stock an “outperform” rating in a research report on Thursday, February 9th. JMP Securities restated an “outperform” rating and set a $32.00 price objective on shares of MINDBODY in a research report on Tuesday, April 4th. Finally, Pacific Crest cut MINDBODY from an “overweight” rating to a “sector weight” rating in a research report on Friday, May 5th.

MINDBODY (NASDAQ:MB) traded up 1.43% on Friday, reaching $28.40. 481,604 shares of the company’s stock were exchanged. The stock’s market capitalization is $1.16 billion. MINDBODY has a 1-year low of $12.99 and a 1-year high of $29.75. The firm’s 50 day moving average is $27.39 and its 200 day moving average is $24.94.

MINDBODY (NASDAQ:MB) last issued its quarterly earnings results on Thursday, May 4th. The technology company reported ($0.03) earnings per share for the quarter, topping the Zacks’ consensus estimate of ($0.05) by $0.02. The firm had revenue of $42.20 million for the quarter, compared to analysts’ expectations of $42.09 million. MINDBODY had a negative return on equity of 22.49% and a negative net margin of 16.53%. MINDBODY’s revenue was up 31.9% on a year-over-year basis. During the same quarter last year, the business posted ($0.12) EPS. Analysts expect that MINDBODY will post ($0.14) EPS for the current year.

WARNING: This article was originally reported by American Banking News and is the property of of American Banking News. If you are viewing this article on another site, it was copied illegally and republished in violation of United States & international copyright and trademark laws. The legal version of this article can be read at https://www.americanbankingnews.com/2017/05/26/mindbody-inc-mb-receives-average-rating-of-buy-from-brokerages.html.

In other MINDBODY news, CFO Brett T. White sold 20,000 shares of the firm’s stock in a transaction dated Monday, April 3rd. The shares were sold at an average price of $27.28, for a total value of $545,600.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Bradford Lee Wills sold 8,172 shares of the firm’s stock in a transaction dated Thursday, March 16th. The stock was sold at an average price of $27.80, for a total transaction of $227,181.60. The disclosure for this sale can be found here. Insiders sold a total of 48,516 shares of company stock valued at $1,328,308 over the last ninety days. 30.62% of the stock is currently owned by corporate insiders.

Large investors have recently bought and sold shares of the company. Quantbot Technologies LP boosted its position in MINDBODY by 96.3% in the first quarter. Quantbot Technologies LP now owns 3,932 shares of the technology company’s stock worth $107,000 after buying an additional 1,929 shares during the period. Legal & General Group Plc boosted its stake in shares of MINDBODY by 4.1% in the first quarter. Legal & General Group Plc now owns 4,218 shares of the technology company’s stock valued at $116,000 after buying an additional 166 shares during the last quarter. Credit Suisse AG acquired a new stake in shares of MINDBODY during the first quarter valued at $220,000. FNY Partners Fund LP acquired a new stake in shares of MINDBODY during the fourth quarter valued at $237,000. Finally, American International Group Inc. boosted its stake in shares of MINDBODY by 7.1% in the first quarter. American International Group Inc. now owns 8,871 shares of the technology company’s stock valued at $244,000 after buying an additional 588 shares during the last quarter. 81.13% of the stock is owned by institutional investors and hedge funds.

About MINDBODY

MINDBODY, Inc is a provider of cloud-based business management software for the wellness services industry and operates as a consumer marketplace with local business subscribers on its platform. The Company’s subscribers provide a range of wellness services to active consumers. Its integrated software and payments platform helps business owners in the wellness services industry run, market and build their businesses.

12 Month Chart for NASDAQ:MB

Receive News & Ratings for MINDBODY Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MINDBODY Inc and related companies with MarketBeat.com's FREE daily email newsletter.